Forward Therapeutics Welcomes Ulrich Thienel, M.D., Ph.D. as Chief Medical Officer

SAN DIEGO, Sept. 3, 2024 /PRNewswire/ — Forward Therapeutics, Inc., a next-generation biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders, today announced the appointment of Ulrich Thienel, M.D., Ph.D., as its Chief Medical Officer. Forward…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.